Correction to Chemically Modified Platforms for Better RNA Therapeutics
Chemical Reviews · 22.05.2024 · 124 (10) · 6690-6692
DOI: 10.1021/acs.chemrev.4c00191 ↗Kurz gefasst
Korrektur in der Zeitschrift Chemical Reviews, online erschienen am 30.04.2024. Verfasst von Yesi Shi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Gefördert von: Novo Nordisk, American Heart Association, Harvard Medical School.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
ORCID-Profile: Yongjiang Li, Na Kong, Gang Liu, Wei Chen, Wei Tao
Förderung
- Novo Nordisk
- American Heart Association
- Harvard Medical School
- American Lung Association
- Brigham Research Institute
- Nanotechnology Foundation
- Khoury College of Computer Sciences
Zitieren
APA
Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024). Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews, 124(10), 6690-6692. https://doi.org/10.1021/acs.chemrev.4c00191
Vancouver
Shi Y, Zhen X, Zhang Y, Li Y, Koo S, Saiding Q, et al. Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews. 2024;124(10):6690-6692. doi:10.1021/acs.chemrev.4c00191
BibTeX
@article{Shi2024,
author = {Shi, Yesi and Zhen, Xueyan and Zhang, Yiming and Li, Yongjiang and Koo, Seyoung and Saiding, Qimanguli and Kong, Na and Liu, Gang and Chen, Wei and Tao, Wei},
title = {Correction to Chemically Modified Platforms for Better RNA Therapeutics},
journal = {Chemical Reviews},
year = {2024},
volume = {124},
number = {10},
pages = {6690--6692},
doi = {10.1021/acs.chemrev.4c00191}
}
EUVIMED